Evaluation of cell death caused by CDF (cyclophosphamide, doxorubicin, 5-fluorouracil) multi-drug administration in the human breast cancer cell line MCF-7

被引:13
作者
Kugawa, F
Ueno, A
Kawasaki, M
Aoki, M
机构
[1] Nihon Univ, Dept Biol Pharmaceut Sci, Coll Pharm, Chiba 2748555, Japan
[2] Univ Tokushima, Sch Med, Dept Biochem, Tokushima 7708504, Japan
关键词
anticancer drug; cyclophosphamide; doxorubicin; 5-fluorouracil; MCF-7; apoptosis;
D O I
10.1248/bpb.27.392
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We evaluated the features of cell death induced by CDF (cyclophosphamide [CPA], doxorubicin [DOX], 5-fluorouracil [5-FU]) multi-drug administration in vitro using the human breast cancer cell line MCF-7. Used individually, DOX and 5-FU induced 60% cell death in MCF-7 cells, at 5 mug/ml and 25 mug/ml, respectively, by the 4th day following drug treatment. CPA was the least cytotoxic of the 3 drugs, causing only 20% cell death, even at the high concentration of 500 mug/ml. Treating cells with a mixture of all three anticancer drugs resulted in 60% cell death, on the second and third day following drug treatment. The nature of the cytotoxicity of CPA, DOX, and 5-FU was investigated, because these drugs are sometimes used to induce apoptosis. Biochemical analysis showed faint DNA fragmentation in the case of DOX or all three drugs, but not for treatment with CPA or 5-FU. In contrast, the morphological apoptotic feature of a condensed nucleus was observed only for CPA and 5-FU. Flow cytometric data agreed with the morphological results in that the FACS cytogram for DOX and for all three drugs was different from that for CPA or 5-FU given alone. These observations suggested that the cell death induced by these anticancer drugs in the human breast cancer cell line MCF-7 is a mixture of apoptotic and non-apoptotic, but it becomes completely non-apoptotic in the case of multi-drug administration.
引用
收藏
页码:392 / 398
页数:7
相关论文
共 22 条
[1]   BREAST-CANCER - CHEMOTHERAPY IN THE TREATMENT OF ADVANCED DISEASE [J].
CLAVEL, M ;
CATIMEL, G .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (04) :598-604
[2]   Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy [J].
Gibson, LF ;
Fortney, J ;
Magro, G ;
Ericson, SG ;
Lynch, JP ;
Landreth, KS .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 55 (02) :107-117
[3]   Strain-specific differences in formation of apoptotic DNA ladders in MCF-7 breast cancer cells [J].
Gooch, JL ;
Yee, D .
CANCER LETTERS, 1999, 144 (01) :31-37
[4]   POTENTIATION OF TAMOXIFEN ACTIVITY BY VERAPAMIL IN A HUMAN BREAST-CANCER CELL-LINE [J].
GUPTA, V ;
KAMATH, N ;
TKALCEVIC, GT ;
SINGH, SV .
BIOCHEMICAL PHARMACOLOGY, 1994, 47 (09) :1701-1704
[5]  
Hahm HA, 2001, CLIN CANCER RES, V7, P391
[6]  
Kugawa F, 2000, BIOL PHARM BULL, V23, P930
[7]   Buprenorphine hydrochloride induces apoptosis in NG108-15 nerve cells [J].
Kugawa, F ;
Arae, K ;
Ueno, A ;
Aoki, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 347 (01) :105-112
[8]  
KUGAWA F, 2003, IN PRESS LIFE SCI
[9]   Apoptosis in the absence of caspase 3 [J].
Liang, Y ;
Yan, CH ;
Schor, NF .
ONCOGENE, 2001, 20 (45) :6570-6578
[10]  
Longley DB, 2002, CANCER RES, V62, P2644